Quarterly report [Sections 13 or 15(d)]

Summary of Significant Accounting Policies (Tables)

v3.25.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2025
Accounting Policies [Abstract]  
Schedule of Anti-dilutive Securities Excluded From Computation of Earnings Per Share The following securities were not included diluted shares outstanding because the effect would be anti-dilutive (in shares).

 

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Warrants

 

 

 

2,847,663

 

 

 

4,625,000

 

 

 

3,952,784

 

 

 

4,625,000

 

Stock options

 

 

 

4,640,337

 

 

 

5,316,451

 

 

 

4,671,438

 

 

 

5,316,451

 

Convertible notes

 

 

 

237,554,699

 

 

 

3,818,611

 

 

 

243,360,690

 

 

 

104,218,359

 

Total anti-dilutive instrument

 

 

 

245,042,699

 

 

 

13,760,062

 

 

 

251,984,912

 

 

 

114,159,810